A detailed history of Eam Investors, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Eam Investors, LLC holds 130,036 shares of CRMD stock, worth $1.05 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
130,036
Previous 104,894 23.97%
Holding current value
$1.05 Million
Previous $454,000 131.28%
% of portfolio
0.18%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.64 - $8.23 $91,516 - $206,918
25,142 Added 23.97%
130,036 $1.05 Million
Q2 2024

Aug 12, 2024

BUY
$4.08 - $6.39 $427,967 - $670,272
104,894 New
104,894 $454,000
Q1 2021

May 11, 2021

SELL
$6.84 - $17.58 $820,813 - $2.11 Million
-120,002 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$5.0 - $9.15 $600,010 - $1.1 Million
120,002 New
120,002 $892,000
Q2 2019

Aug 14, 2019

SELL
$5.93 - $10.57 $868,578 - $1.55 Million
-146,472 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$6.95 - $13.25 $1.02 Million - $1.94 Million
146,472 New
146,472 $1.38 Million

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $334M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Eam Investors, LLC Portfolio

Follow Eam Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Investors, LLC with notifications on news.